Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enalapril increases cardiac refractoriness.

W C De Mello1, M J Crespo, P I Altieri

  • 1Department of Pharmacology, University of Puerto Rico, San Juan.

Journal of Cardiovascular Pharmacology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Next-generation three-dimensional modelling software for personalized surgery decision-making in perihilar cholangiocarcinoma: multicentre study.

The British journal of surgery·2021
Same author

Intracellular angiotensin-(1-12) changes the electrical properties of intact cardiac muscle.

Molecular and cellular biochemistry·2016
Same author

[Cilioretinal artery occlusion in hemochromatosis].

Archivos de la Sociedad Espanola de Oftalmologia·2014
Same author

Parallel regulation of arginine transport and nitric oxide synthesis by angiotensin II in vascular smooth muscle cells role of protein kinase C.

Amino acids·2013
Same author

Further studies on the effects of intracrine and extracellular angiotensin II on the regulation of heart cell volume. On the influence of aldosterone and spironolactone.

Regulatory peptides·2010
Same author

The atherosclerotic plaque.

Puerto Rico health sciences journal·2008
Same journal

Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

Journal of cardiovascular pharmacology·2026
Same journal

A Comprehensive Review of PCSK9 Inhibitor Therapy.

Journal of cardiovascular pharmacology·2026
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
See all related articles

Enalapril, an angiotensin converting enzyme inhibitor, increases cardiac refractoriness and action potential amplitude. This suggests potential anti-arrhythmic properties for the drug.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Cardiac refractoriness is crucial for preventing arrhythmias.
  • Angiotensin converting enzyme (ACE) inhibitors are widely used cardiovascular drugs.

Purpose of the Study:

  • To investigate the effects of enalapril on cardiac refractoriness.
  • To determine the impact of enalapril on electrophysiological properties of cardiac tissue.

Main Methods:

  • Strength-interval curves were obtained under control and enalapril-treated conditions.
  • Cardiac muscle exposure to enalapril (50 µg/ml) in Tyrode solution.

Main Results:

  • Enalapril shifted strength-interval curves to the right, increasing the minimal current intensity required for a propagated response.

Related Experiment Videos

  • No significant change in action potential duration was observed.
  • Enalapril increased action potential amplitude and resting potential.
  • Conclusions:

    • Enalapril elevates cardiac refractoriness.
    • The observed increase in refractoriness suggests enalapril may possess anti-arrhythmic properties.